SPAZO2 (SOGUG): Validation of the international metastatic database consortium (IMDC) prognostic classification for targeted therapies as 2nd-line after 1st-line pazopanib (1stPz) in metastatic renal cell carcinoma (mRC)

Authors :: Perez-Valderrama B
Arija J
Gonzalez I
Herranz U
Garcia J
Rodriguez C
Carbonero I
de Velasco G
Dominguez R
Marrero R
Baamonde M
Palau C
Lazaro M
Munoz-Langa J
Ortega E
Jorge A
Guillaumes M
Moyano M
Caro R
Sanchez A
Source :: ANNALS OF ONCOLOGY, r-FISABIO. Repositorio Institucional de Producción Científica, instname
Publication Year :: 2017
Publisher :: OXFORD UNIV PRESS, 2017.

ISSN :: 09237534
Database :: OpenAIRE
Journal :: ANNALS OF ONCOLOGY, r-FISABIO. Repositorio Institucional de Producción Científica, instname
Accession number :: edsair.RECOLECTA.....a6776e070495e54d95e4f52b55cf9524

Tools